Claris Lifesciences Financials

BSE: 533288

₹396.55

₹-0.25 (-0.06%)

As on 14-Mar-2018IST

Market cap

₹2,164 Cr

Revenue (TTM)

₹-- Cr

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Dec-13	Dec-12	Dec-11	Dec-10
Operating Revenue	--	--	--	46.29	874.58	133.16
Total Income	0.04	0.46	7.63	60.20	886.47	282.17
Total Expenditure	0.31	1.45	12.47	31.73	623.58	243.07
EBITDA	-0.31	-1.45	-12.47	14.56	251.00	-109.90
Depreciation	--	--	--	0.10	31.31	3.86
EBIT	-0.31	-1.45	-12.47	14.46	219.70	-113.76
Interest	0.00	0.00	--	--	43.03	5.48
Other Income	0.04	0.46	7.63	13.92	11.89	149.01
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.27	-1.00	-4.84	28.37	188.56	29.77
Provision for Tax	--	4.01	2.65	12.81	52.54	-22.92
Profit after Tax	-0.27	-5.01	-7.49	15.56	136.02	52.69
Minority Interest	--	--	--	1.44	--	--
Share of Associate	--	--	--	--	-26.09	-92.12
Consolidated Profit	-0.27	-5.01	-7.49	17.00	109.93	-39.44

Liabilities (₹ Cr)	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Dec-13	Dec-12	Dec-11	Dec-10
Shareholder's Funds	-11.66	-11.39	-6.38	0.70	1,019.94	919.51
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	-5.28	-5.28	-9.56	-12.21	17.39	359.43
Current Liabilities	21.45	21.37	28.11	23.32	738.70	457.79
Total Liabilities	9.79	9.98	21.73	24.03	1,782.16	1,747.30

Assets (₹ Cr)	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Dec-13	Dec-12	Dec-11	Dec-10
Non-Current Assets	1.05	1.05	6.35	6.27	189.85	1,026.11
Current Assets	3.46	3.66	5.82	5.55	1,586.18	710.62
Total Assets	9.79	9.98	21.73	24.03	1,782.16	1,747.30
Total Debt*	21.01	20.97	27.63	--	21.56	598.73
Net Current Assets	-17.99	-17.71	-22.28	-17.77	847.48	252.83
Contingent Liabilities	13.19	30.26	32.70	32.72	162.13	148.00

Cashflow (₹ Cr)	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Dec-13	Dec-12	Dec-11	Dec-10
Cash From Operating Activities	-0.11	6.17	-7.85	-5.82	179.35	20.46
Cash Flow from Investing Activities	0.05	0.41	0.35	13.47	-58.46	56.80
Cash from Financing Activities	-0.01	-6.67	7.70	-13.14	-105.49	22.28
Net Cash Inflow / Outflow	-0.06	-0.09	0.21	-5.49	15.41	99.54

Financials Ratios	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Dec-13	Dec-12	Dec-11	Dec-10
Adjusted EPS (₹)	-0.05	-0.92	-1.37	3.11	20.14	-7.23
Cash EPS (₹)	-0.05	-0.92	-1.37	2.87	30.66	10.36
Adjusted Book Value (₹)	-2.14	-2.09	-1.17	0.13	186.91	168.51
Dividend per Share (₹)	--	--	--	--	2.00	2.00
Cash Flow per Share (₹)	-0.02	1.13	-1.44	-1.07	32.87	3.75
Free Cash Flow per Share (₹)	-0.01	-0.65	-1.94	3.31	18.50	-24.15

Profitability Ratios	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Dec-13	Dec-12	Dec-11	Dec-10
ROCE (%)	-2.88	-6.46	-44.11	5.45	18.09	2.09
ROE (%)	--	--	--	3.05	14.03	4.71
ROA (%)	-5.93	-59.40	-62.45	1.74	7.74	2.69
EBIT Margin (%)	--	--	--	31.23	25.12	-85.43
Net Margin (%)	-661.02	-1,091.55	-98.22	25.85	15.34	18.67
Cash Profit Margin (%)	--	--	--	33.84	19.13	42.46

Growth Ratios	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Dec-13	Dec-12	Dec-11	Dec-10
Revenue Growth (%)	--	--	-100.00	-94.71	556.78	-83.35
EBIT Growth (%)	78.42	88.33	-186.25	-93.42	293.12	-206.89
Net Profit Growth (%)	94.55	33.09	-148.14	-88.56	158.17	-66.37
EPS Growth (%)	94.56	33.08	-144.07	-84.54	378.75	-126.38
Book Value Growth (%)	-2.40	-78.62	-1,005.14	-99.93	10.92	-30.17

Valuation Ratios	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Dec-13	Dec-12	Dec-11	Dec-10
Price / Earnings	--	--	--	127.31	15.91	--
Price / Book Value	--	--	--	3,071.96	1.71	0.77
Dividend Yield (%)	--	--	--	--	0.62	1.53
EV/EBITDA	-275.51	-75.29	-16.83	75.97	6.62	28.76
Close Price (₹)	--	--	--	396.55	320.50	130.50
High Price (₹)	--	--	--	425.70	430.10	358.00
Low Price (₹)	--	--	--	308.00	130.50	126.10
Market Cap (₹ Cr)	--	--	--	2,163.89	1,748.90	712.11

Solvency Ratios	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Dec-13	Dec-12	Dec-11	Dec-10
Debt to Equity	-1.80	-1.84	-4.33	--	0.02	0.65
Short term debt to equity ratio	-1.80	-1.84	-4.33	--	--	0.19
Current Ratio	0.16	0.17	0.21	0.24	2.15	1.55
Quick Ratio	0.16	0.17	0.21	0.24	2.15	1.35
Interest Coverage	-681.50	-452.59	--	--	5.38	6.43

Operating Efficiency Ratios	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Dec-13	Dec-12	Dec-11	Dec-10
Debtors to sales (%)	--	--	--	1.26	2.07	125.73
Asset Turnover	--	--	--	0.05	0.50	0.07
Receivable days	--	--	--	73.78	38.72	543.50
Inventory Days	--	--	--	--	--	258.25
Payable days	--	--	--	--	--	485.40
Cash Conversion Cycle	--	--	--	--	--	316.35